High-Dose Ambroxol in Pediatric Type III Gaucher Disease (GD3)

Clinical trial NCT07285369 · TERMINATED

Trial details

NCT number: NCT07285369
Sponsor: Agyany Pharma LTD
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

Gaucher Disease, Type 3

Start date: 2025-03-01
Primary completion: 2026-03-30
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.